News about our campaigns and health policy.
Response to news that breast cancer drug palbociclib could be temporarily available to NHS patients for free
Thursday 4 May 2017
Short-term victory for campaigners as Pfizer offers drug free-of-charge to the NHS in the interim, while NICE...
Response to new study suggesting that the Cancer Drugs Fund 'failed to deliver meaningful value to patients and society'
Friday 28 April 2017
In a study published today in journal Annals of Oncology, new analysis of drugs that were approved for use by the...
Monday 10 April 2017
The Scottish Medicines Consortium (SMC) has today (Monday 10 April) announced a landmark decision to make the...
Breast Cancer Now responds to NICE and NHS England proposal that could delay access to one in five new drugs
Wednesday 15 March 2017
Breast Cancer Now is one of 21 charities that have expressed major concerns about a proposal from NHS England...
Response to new Screening Programme stats showing slight increase in uptake for first time in five years
Thursday 23 February 2017
Statistics from the NHS Breast Screening Programme in England show a slight increase in uptake of routine...
Thursday 9 February 2017
Breast Cancer Now responds to NICE decision to recommend controlled use of Intrabeam...
Friday 3 February 2017
The National Institute for Health and Care Excellence (NICE) has today published draft guidance which does not...
Campaigners deliver 115,898 signatures urging NICE and Roche to save breast cancer drug Kadcyla on the NHS
Tuesday 24 January 2017
Campaigners living with incurable secondary breast cancer today joined Breast Cancer...
Breast Cancer Now launches urgent petition following NICE decision to reject Kadcyla for routine use on the NHS
Thursday 29 December 2016
The National Institute for Health and Care Excellence (NICE) has today announced that...
Tuesday 29 November 2016
Read our CEO, Baroness Delyth Morgan's, response to NICE's updated clinical guidance for familial breast cancer and...